Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of an antagonist of α5β1 for anti-angiogenesis and cancer treatment

Administration of an antagonist of α5β1 for anti-angiogenesis and cancer treatment

US Patent 8946159 · Granted Feb 3, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-angiogenic treatment using VLO4 with a blocking peptide2024
Combination therapies for inhibiting sprout angiogenesis in the treatment of can2024
Anti-angiogenic treatment with a combination of antagonists2022
High-low temperature radiator for internal combustion engine engineering machine2022
Compositions for inhibiting sprout angiogenesis2021
Anti-angiogenic treatment of endothelial tissue with a combination of antagonist2020
Formulations having an antagonist of α5β1 for anti-angiogenesis and cancer treat2014
Light-emitting devices with fullerene layer2009